BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 9541504)

  • 1. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.
    Linton MF; Hasty AH; Babaev VR; Fazio S
    J Clin Invest; 1998 Apr; 101(8):1726-36. PubMed ID: 9541504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor.
    Herz J; Qiu SQ; Oesterle A; DeSilva HV; Shafi S; Havel RJ
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4611-5. PubMed ID: 7753850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.
    Véniant MM; Zlot CH; Walzem RL; Pierotti V; Driscoll R; Dichek D; Herz J; Young SG
    J Clin Invest; 1998 Oct; 102(8):1559-68. PubMed ID: 9788969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice.
    Martins IJ; Hone E; Chi C; Seydel U; Martins RN; Redgrave TG
    J Lipid Res; 2000 Feb; 41(2):205-13. PubMed ID: 10681404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E.
    Mahley RW; Ji ZS
    J Lipid Res; 1999 Jan; 40(1):1-16. PubMed ID: 9869645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins.
    Fischer AW; Albers K; Krott LM; Hoffzimmer B; Heine M; Schmale H; Scheja L; Gordts PLSM; Heeren J
    Mol Metab; 2018 Oct; 16():88-99. PubMed ID: 30100244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoE-deficient mice. Evidence for slow metabolism via an alternative apoE-dependent pathway.
    Mortimer BC; Beveridge DJ; Martins IJ; Redgrave TG
    J Biol Chem; 1995 Dec; 270(48):28767-76. PubMed ID: 7499399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice.
    Hu L; Boesten LS; May P; Herz J; Bovenschen N; Huisman MV; Berbée JF; Havekes LM; van Vlijmen BJ; Tamsma JT
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2710-5. PubMed ID: 17038633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of apo E-containing lipoproteins with the LDL-receptor-related protein, LRP.
    Harrach-Ruprecht B; Küchenhoff A; Robenek H
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():122-3. PubMed ID: 8767486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipoprotein metabolism in transgenic mice overexpressing apolipoprotein E. Accelerated clearance of lipoproteins containing apolipoprotein B.
    Shimano H; Yamada N; Katsuki M; Yamamoto K; Gotoda T; Harada K; Shimada M; Yazaki Y
    J Clin Invest; 1992 Nov; 90(5):2084-91. PubMed ID: 1430232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist.
    Willnow TE; Sheng Z; Ishibashi S; Herz J
    Science; 1994 Jun; 264(5164):1471-4. PubMed ID: 7515194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In LDL receptor-deficient mice, catabolism of remnant lipoproteins requires a high level of apoE but is inhibited by excess apoE.
    van Dijk KW; van Vlijmen BJ; van't Hof HB; van der Zee A; Santamarina-Fojo S; van Berkel TJ; Havekes LM; Hofker MH
    J Lipid Res; 1999 Feb; 40(2):336-44. PubMed ID: 9925664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans.
    Ji ZS; Sanan DA; Mahley RW
    J Lipid Res; 1995 Mar; 36(3):583-92. PubMed ID: 7539827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
    Zsigmond E; Kobayashi K; Tzung KW; Li L; Fuke Y; Chan L
    Hum Gene Ther; 1997 Nov; 8(16):1921-33. PubMed ID: 9382958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein.
    Beisiegel U; Weber W; Ihrke G; Herz J; Stanley KK
    Nature; 1989 Sep; 341(6238):162-4. PubMed ID: 2779654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
    van der Hoogt CC; Berbée JF; Espirito Santo SM; Gerritsen G; Krom YD; van der Zee A; Havekes LM; van Dijk KW; Rensen PC
    Biochim Biophys Acta; 2006 Feb; 1761(2):213-20. PubMed ID: 16478678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice.
    Foley EM; Gordts PLSM; Stanford KI; Gonzales JC; Lawrence R; Stoddard N; Esko JD
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2065-74. PubMed ID: 23846497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDL receptor-related protein mediates cell-surface clustering and hepatic sequestration of chylomicron remnants in LDLR-deficient mice.
    Yu KC; Chen W; Cooper AD
    J Clin Invest; 2001 Jun; 107(11):1387-94. PubMed ID: 11390420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.